Vice President, Biomarker & BioAnalytical Sciences
Sangamo Therapeutics
Richmond, California
Dr. Yanmei Lu is currently the VP of Biomarker and BioAnalytical Sciences at Sangamo Therapeutics. Her group supports gene and cell therapy programs at both preclinical and clinical stages: Biomarker strategy, Bioanalysis and Companion diagnostic development. Dr. Lu holds a PhD in Biochemistry and Molecular Biology from University of South Florida and has published over 50 peer-reviewed articles/book chapters. She is the editor and author of the bestseller book on Amazon for gene therapy drug development.
Disclosure information not submitted.
Hot Topic: Industry Discussions on Companion Diagnostics for AAV-Mediated Gene Therapy
Tuesday, May 6, 2025
10:00 AM - 11:00 AM ET